209 related articles for article (PubMed ID: 11312338)
1. Efficient conversion of normal prion protein (PrP) by abnormal hamster PrP is determined by homology at amino acid residue 155.
Priola SA; Chabry J; Chan K
J Virol; 2001 May; 75(10):4673-80. PubMed ID: 11312338
[TBL] [Abstract][Full Text] [Related]
2. Octapeptide repeat insertions increase the rate of protease-resistant prion protein formation.
Moore RA; Herzog C; Errett J; Kocisko DA; Arnold KM; Hayes SF; Priola SA
Protein Sci; 2006 Mar; 15(3):609-19. PubMed ID: 16452616
[TBL] [Abstract][Full Text] [Related]
3. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.
Horiuchi M; Caughey B
EMBO J; 1999 Jun; 18(12):3193-203. PubMed ID: 10369660
[TBL] [Abstract][Full Text] [Related]
4. A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells.
Priola SA; Chesebro B
J Virol; 1995 Dec; 69(12):7754-8. PubMed ID: 7494285
[TBL] [Abstract][Full Text] [Related]
5. Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease.
Raymond GJ; Bossers A; Raymond LD; O'Rourke KI; McHolland LE; Bryant PK; Miller MW; Williams ES; Smits M; Caughey B
EMBO J; 2000 Sep; 19(17):4425-30. PubMed ID: 10970836
[TBL] [Abstract][Full Text] [Related]
6. N-terminal truncation of prion protein affects both formation and conformation of abnormal protease-resistant prion protein generated in vitro.
Lawson VA; Priola SA; Wehrly K; Chesebro B
J Biol Chem; 2001 Sep; 276(38):35265-71. PubMed ID: 11466311
[TBL] [Abstract][Full Text] [Related]
7. Deletion of beta-strand and alpha-helix secondary structure in normal prion protein inhibits formation of its protease-resistant isoform.
Vorberg I; Chan K; Priola SA
J Virol; 2001 Nov; 75(21):10024-32. PubMed ID: 11581371
[TBL] [Abstract][Full Text] [Related]
8. Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein.
Wong C; Xiong LW; Horiuchi M; Raymond L; Wehrly K; Chesebro B; Caughey B
EMBO J; 2001 Feb; 20(3):377-86. PubMed ID: 11157745
[TBL] [Abstract][Full Text] [Related]
9. Measurement of altered aspartyl residues in the scrapie associated form of prion protein.
Weber DJ; McFadden PN; Caughey B
Biochem Biophys Res Commun; 1998 May; 246(3):606-8. PubMed ID: 9618258
[TBL] [Abstract][Full Text] [Related]
10. Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers.
Horiuchi M; Priola SA; Chabry J; Caughey B
Proc Natl Acad Sci U S A; 2000 May; 97(11):5836-41. PubMed ID: 10811921
[TBL] [Abstract][Full Text] [Related]
11. Effect of transition metals (Mn, Cu, Fe) and deoxycholic acid (DA) on the conversion of PrPC to PrPres.
Kim NH; Choi JK; Jeong BH; Kim JI; Kwon MS; Carp RI; Kim YS
FASEB J; 2005 May; 19(7):783-5. PubMed ID: 15758042
[TBL] [Abstract][Full Text] [Related]
12. Abnormal properties of prion protein with insertional mutations in different cell types.
Priola SA; Chesebro B
J Biol Chem; 1998 May; 273(19):11980-5. PubMed ID: 9565627
[TBL] [Abstract][Full Text] [Related]
13. Strain-specific effects of reducing agents on the cell-free conversion of recombinant prion protein into a protease-resistant form.
Imamura M; Kato N; Okada H; Iwamaru Y; Shimizu Y; Mohri S; Yokoyama T
Microbiol Immunol; 2011 Sep; 55(9):633-40. PubMed ID: 21645053
[TBL] [Abstract][Full Text] [Related]
14. Sites of prion protein accumulation in scrapie-infected mouse spleen revealed by immuno-electron microscopy.
Jeffrey M; McGovern G; Goodsir CM; Brown KL; Bruce ME
J Pathol; 2000 Jul; 191(3):323-32. PubMed ID: 10878556
[TBL] [Abstract][Full Text] [Related]
15. Prion protein and species barriers in the transmissible spongiform encephalopathies.
Priola SA
Biomed Pharmacother; 1999; 53(1):27-33. PubMed ID: 10221165
[TBL] [Abstract][Full Text] [Related]
16. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
17. Prion-protein-specific aptamer reduces PrPSc formation.
Proske D; Gilch S; Wopfner F; Schätzl HM; Winnacker EL; Famulok M
Chembiochem; 2002 Aug; 3(8):717-25. PubMed ID: 12203970
[TBL] [Abstract][Full Text] [Related]
18. Glycosylation influences cross-species formation of protease-resistant prion protein.
Priola SA; Lawson VA
EMBO J; 2001 Dec; 20(23):6692-9. PubMed ID: 11726505
[TBL] [Abstract][Full Text] [Related]
19. Comparison of protease-resistant prion protein inhibitors in cell cultures infected with two strains of mouse and sheep scrapie.
Kocisko DA; Engel AL; Harbuck K; Arnold KM; Olsen EA; Raymond LD; Vilette D; Caughey B
Neurosci Lett; 2005 Nov; 388(2):106-11. PubMed ID: 16039063
[TBL] [Abstract][Full Text] [Related]
20. Specific inhibition of pathological prion protein accumulation by small interfering RNAs.
Daude N; Marella M; Chabry J
J Cell Sci; 2003 Jul; 116(Pt 13):2775-9. PubMed ID: 12759373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
